Andrea Sitlinger is malignant hematologist at Duke Cancer Institute. She specializes in CLL and other mature B cell lymphomas. Her research is focused on improving outcomes and population health. Specifically, she focuses on adjuncts to cancer care such exercise, co-morbidity management, cancer screenings, and financial toxicity.  Maximizing patient care continues to be her driving force and she strives to improve the outcomes of hematologic malignancies through individual patient care, active clinical research, and systems improvement. She also is passionate about educating the next generation of physicians and focuses on educating hematology/oncology fellows as an associate program director.